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Abstract: Approximately 11 million new cases of cancer are diag-
nosed worldwide each year; one in eight is a lung cancer. More than
one million people die of lung cancer each year, and non-small cell
lung cancer accounts for approximately 80% of all cases of lung
cancer. The incidence of primary tumors that metastasize to the orbit
is approximately 7%. In 19% of the cases, there is no history of
cancer when the patient presents with ophthalmic symptoms, and in
10%, the primary site remains obscure despite intensive systemic
evaluation. We report a rare form of clinical presentation of non-
small cell lung cancer in which symptoms caused by orbital metas-
tases were the first manifestations.
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CASE REPORT
A 69-year-old white man who was a heavy smoker
presented with reduced vision in his left eye, double vision,
persistent pain in the left frontal-parietal region, and in-
creased pressure on the left orbit for the past 3 months. He
had no nausea, vomiting, or respiratory symptoms. The pa-
tient’s medical history included hypertension, ischemic heart
disease diagnosed 5 years earlier, and high blood cholesterol
level, and he used regular medication. He had no family
history of malignant diseases.
The physical examination showed proptosis, lid ptoses,
and a tender palpable mass on the left eye (Figure 1). There were
no lymphadenopathies. The chest and heart sounds were normal.
The abdominal examination was normal. There were no relevant
focal neurological deficits. Visual acuity of the right eye was
normal and reduced to half on the left eye. A spontaneous
subcapsular hemorrhage was observed on the left eye.
Laboratory testing revealed no abnormal values. The pros-
tate-specific antigen was normal. A chest radiograph showed a
4-cm nodule in the left lower lobe. Computed tomographic
scanning of the brain revealed a 2-cm solid tissue mass localized
on the left orbit. The thoracic scan showed a 3-cm nodule in the
inferior lobe of the left lung and a pleural thickening, a 2-cm
right hilar lymph node, and para-aorthic lymph nodes with 1.5
cm. A brain magnetic resonance image showed a 2.2  1.7-cm
mass in the left orbit and no parenchymal changes (Figure 2). A
Department of Medical Oncology, Portuguese Institute of Oncology, Oporto,
Portugal.
Address for correspondence: Joana Espiga Macedo, MD, Department of Med-
ical Oncology, Portuguese Institute of Oncology, Rua Dr. Ant. Bernardino
Almeida, 4200-072 Porto, Portugal. E-mail: joanamacedo@hotmail.com
Copyright © 2007 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/07/0202-0166
FIGURE 1. Proptosis, lid ptoses, and a tender palpable
mass on the left eye.
FIGURE 2. Brain magnetic resonance image showing a 2.2 
1.7-cm mass in the left orbit.
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bone scan showed extensive osteoblastic metastases. The patient
refused to perform an orbital biopsy aspirate, preferring a pleural
biopsy, which revealed lung adenocarcinoma.
The patient was treated with carboplatin (area under the
curve 6; D1) and gemcitabine (1000 mg/m2, D1 and D8) with
a 3-week interval and 90 mg pamidronate each 3 weeks. Tho-
racic and abdominal computed tomographic scans showed right
pulmonary effusion and newmultiple hepatic nodules in favor of
secondary lesions after the fourth cycle.
On the 13th day of the fourth cycle, the patient pre-
sented with a sudden left chest pain. The electrocardiogram
revealed signs of inferior acute myocardial infarction. Car-
diac enzymes were increased. The patient died of acute
myocardial infarction.
DISCUSSION
In 1864, Horner published the first case of orbital
metastases,1 which represent approximately 60% of the cases
of first clinical manifestation of malignant disease.2 The most
frequent clinical findings are limited ocular motility (54%),
proptosis (50%), and a palpable mass (43%). The cancers that
most commonly metastasize to the orbit are breast (53%),
prostate gland, (12%) and lung cancers (8%). Metastases of
primary tumors can involve the orbit by the bloodstream.3,4
The clinical presentation depends on the nature of the
primary tumor, the speed of progression, and the immuno-
logical situation of the patient. Considering the challenge of
diagnosing the primary tumor of orbital metastases, a breast
examination should be performed for women, and a prostate
evaluation should be performed for men. For both, lung
cancer diagnosis should be excluded.
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